Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?

Giacomo Grasselli, Beatrice Vergnano, Maria Rosa Pozzi, Vittoria Sala, Gabriele D’Andrea, Vittorio Scaravilli, Marco Mantero, Alberto Pesci, Antonio Pesenti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71%) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71%), while the subgroup of patients without risk factors had a markedly lower survival (38%). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.

Original languageEnglish
Article number98
JournalAnnals of Intensive Care
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Interstitial Lung Diseases
Adult Respiratory Distress Syndrome
Critical Illness
Autoantibodies
Extracorporeal Membrane Oxygenation
Connective Tissue Diseases
Survival
Berlin
Immunosuppressive Agents
Artificial Respiration
Intensive Care Units

Keywords

  • ARDS
  • ECMO
  • Interstitial pneumonia with autoimmune features
  • Lung-dominant connective tissue disease

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Interstitial pneumonia with autoimmune features : an additional risk factor for ARDS? / Grasselli, Giacomo; Vergnano, Beatrice; Pozzi, Maria Rosa; Sala, Vittoria; D’Andrea, Gabriele; Scaravilli, Vittorio; Mantero, Marco; Pesci, Alberto; Pesenti, Antonio.

In: Annals of Intensive Care, Vol. 7, No. 1, 98, 01.12.2017.

Research output: Contribution to journalArticle

Grasselli, Giacomo ; Vergnano, Beatrice ; Pozzi, Maria Rosa ; Sala, Vittoria ; D’Andrea, Gabriele ; Scaravilli, Vittorio ; Mantero, Marco ; Pesci, Alberto ; Pesenti, Antonio. / Interstitial pneumonia with autoimmune features : an additional risk factor for ARDS?. In: Annals of Intensive Care. 2017 ; Vol. 7, No. 1.
@article{a7a0310e5a0142a89db4790328cb9098,
title = "Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?",
abstract = "Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71{\%}) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71{\%}), while the subgroup of patients without risk factors had a markedly lower survival (38{\%}). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.",
keywords = "ARDS, ECMO, Interstitial pneumonia with autoimmune features, Lung-dominant connective tissue disease",
author = "Giacomo Grasselli and Beatrice Vergnano and Pozzi, {Maria Rosa} and Vittoria Sala and Gabriele D’Andrea and Vittorio Scaravilli and Marco Mantero and Alberto Pesci and Antonio Pesenti",
year = "2017",
month = "12",
day = "1",
doi = "10.1186/s13613-017-0320-3",
language = "English",
volume = "7",
journal = "Annals of Intensive Care",
issn = "2110-5820",
publisher = "Springer-Verlag GmbH and Co. KG",
number = "1",

}

TY - JOUR

T1 - Interstitial pneumonia with autoimmune features

T2 - an additional risk factor for ARDS?

AU - Grasselli, Giacomo

AU - Vergnano, Beatrice

AU - Pozzi, Maria Rosa

AU - Sala, Vittoria

AU - D’Andrea, Gabriele

AU - Scaravilli, Vittorio

AU - Mantero, Marco

AU - Pesci, Alberto

AU - Pesenti, Antonio

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71%) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71%), while the subgroup of patients without risk factors had a markedly lower survival (38%). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.

AB - Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71%) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71%), while the subgroup of patients without risk factors had a markedly lower survival (38%). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.

KW - ARDS

KW - ECMO

KW - Interstitial pneumonia with autoimmune features

KW - Lung-dominant connective tissue disease

UR - http://www.scopus.com/inward/record.url?scp=85029749710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029749710&partnerID=8YFLogxK

U2 - 10.1186/s13613-017-0320-3

DO - 10.1186/s13613-017-0320-3

M3 - Article

AN - SCOPUS:85029749710

VL - 7

JO - Annals of Intensive Care

JF - Annals of Intensive Care

SN - 2110-5820

IS - 1

M1 - 98

ER -